New gene therapy aims to reverse Age-Related muscle decline

NCT ID NCT07443826

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a gene therapy designed to help older adults regain muscle mass and strength lost with age. The treatment uses a harmless virus to deliver a gene that promotes muscle growth, sometimes combined with another gene that improves blood flow. The trial involves 12 participants and focuses on safety, while also looking for signs of improved muscle function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MUSCLE DECLINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Muscle Weakness muscular atrophy Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • GARM

    RECRUITING

    Coxen Hole, Bay Islands, 34101, Honduras

    Contact Phone: •••-•••-•••• Email: •••••@•••••